At the last check on Friday, LifeMD Inc.’s (NASDAQ:LFMD) stock was up $0.24, moving up 6.22 percent to $4.10. The average number of shares traded per day over the past five days has been 312,331 shares. 4 times new highs have been achieved over the past 5 days, with a $0.48 gain in that time frame. In the last twenty days, the average volume was 332,058, while in the previous 50 days, it was 441,329.
Since last month, LFMD stock retreated -2.84%. Shares of the company fell to $3.45 on 08/09/23, the lowest level in the past month. A 52-week high of $5.45 was reached on 07/11/23 after having rallying from a 52-week low of $1.14. Since the beginning of this year, LFMD’s stock price has risen by 111.34% or $2.13, and marked a new high 22 times. However, the stock has declined by -24.77% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
LFMD stock investors should be aware that LifeMD Inc. (LFMD) stock had its last reported insider trading activity 1 day ago on Aug 31. Velge Bertrand, the Director of the company, purchased of 60,000 shares for $3.93 on Aug 31. It resulted in a $235,800 investment by the insider. Velge Bertrand added 40,000 shares at an average price of $3.76 on Aug 30. The insider now owns 289,482 shares following the transaction. On Aug 29, Director Velge Bertrand bought 32,072 shares at $3.58 apiece. The transaction was valued at $114,818.
Financial Health
In the three months ended June 30, LifeMD Inc.’s quick ratio stood at 0.60, while its current ratio was 0.70, showing that the company is not able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 85.70% percent. In the year ended June 30, EBITDA margin amounted to -30.17%, whereas operating margins totaled -35.30%. Based on annual data, LFMD earned $100.37 million in gross profit and brought in $119.03 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 508.70%. Return on equity (ROE) for the past 12 months was 950.90%.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. LFMD’s revenue rose 17.97% to $33.13 million during the quarter, while net income inched up to $35.4 million. While analysts expected LifeMD Inc. to report -$0.1 quarterly earnings, the actual figure was -$0.23 per share. During the quarter, the company generated -$3.23 million in EBITDA. The liabilities of LifeMD Inc. were 45.65 million at the end of its most recent quarter ended June 30, and its total debt was $15.31 million. The value of shareholders’ equity is $36.03 million.
Technical Picture
This quick technical analysis looks at LifeMD Inc.’s (LFMD) price momentum. With a historical volatility rate of 139.87%, the RSI 9-day stood at 58.19% on 31 August.
With respect to its five-day moving average, the current LifeMD Inc. price is up by +13.51% percent or $0.48. At present, LFMD shares trade -5.45% below its 20-day simple moving average and +144.01% percent above its 100-day simple moving average. However, the stock is currently trading approximately +11.64% above its SMA50 and +61.71% above its SMA200.
Stochastic coefficient K was 42.64% and Stochastic coefficient D was 30.49%, while ATR was 0.31. Given the Stochastic reading of 57.48% for the 14-day period, the RSI (14) reading has been calculated as 53.93%. As of today, the MACD Oscillator reading stands at 0.17, while the 14-day reading stands at 0.10.
Analyst Ratings
Cantor Fitzgerald launched its rating on LifeMD Inc. (NASDAQ: LFMD) to an Overweight in a note to investors on July 21, 2023. LifeMD Inc. (LFMD) has been rated Buy by analysts. According to 0 brokerage firms, LFMD is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate LifeMD Inc. stock as buy, with 4 recommending it as overweight.
With a median target price of $7.00, the current consensus forecast for the stock is $7.00 – $9.00. Based on these forecasts, analysts predict LifeMD Inc. (LFMD) will achieve an average price target of $7.50.
